HEAT BIOLOGICS, INC. Contracts & Agreements
211 Contracts & Agreements
- Business Finance (75 contracts)
- Business Operations (14)
- Human Resources (58)
- Intellectual Property (32)
- Mergers & Acquisitions (1)
- Real Estate (8)
- Uncategorized (23)
- Amendment No. 7 to the Rights Agreement dated as of March 11, 2024 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 13, 2024)
- Underwriting Agreement dated March 7, 2024 (Filed With SEC on March 11, 2024)
- Note in the principal amount of $2,250,000 issued to Elusys Holdings Inc (Filed With SEC on January 30, 2024)
- Patent Rights Sale and Assignment Agreement between NightHawk Biosciences, Inc. and Kopfkino IP, LLC (Filed With SEC on January 30, 2024)
- Asset and Equity Interests Purchase Agreement by and between NightHawk Biosciences, Inc. and Elusys Holdings Inc., dated as December 11, 2023 (Filed With SEC on December 12, 2023)
- Amendment No. 6 to the Rights Agreement dated as of December 11, 2023 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8,... (Filed With SEC on December 12, 2023)
- Form of Convertible Note (Filed With SEC on December 12, 2023)
- Amendment No. 2 to William Ostrander Employment Agreement with the Company dated as of December 11, 2023 (Filed With SEC on December 12, 2023)
- Form of Shared Services Agreement between NightHawk Biosciences, Inc. and Elusys Holdings Inc (Filed With SEC on December 12, 2023)
- Sales Agreement, dated December 8, 2023, by and between NightHawk Biosciences, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on December 8, 2023)
- Ordering Agreement between Lonza Sales AG and Elusys Therapeutcs, Inc (Filed With SEC on March 31, 2023)
- Ordering Agreement between Lonza Sales AG and Elusys Therapeutcs, Inc (Filed With SEC on March 31, 2023)
- Amendment No. 5 to the Rights Agreement dated as of March 11, 2023 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 13, 2023)
- Amendment No. 1 to Jeff Wolf Employment Agreement with the Company dated as of December 7, 2022 (Filed With SEC on December 9, 2022)
- Amendment No. 1 to William Ostrander Employment Agreement with the Company dated as of December 7, 2022 (Filed With SEC on December 9, 2022)
- Patent License Agreement between the Board of Regents of the University of Texas System and Elusys Therapeutics, Inc (Filed With SEC on April 20, 2022)
- Description of Securities of Heat Biologics, Inc (Filed With SEC on March 11, 2022)
- License Agreement by and between University of Miami and Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.), dated July 11, 2008, (UM03-31, UM05-39) (Filed With SEC on March 11, 2022)
- License Agreement by and between University of Miami and Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) dated December 12, 2010 (UMI176) (Filed With SEC on March 11, 2022)
- Amendment to License Agreement between Heat Biologics, Inc. and University of Miami (UM03-31, UM05-39) dated April 20, 2009 (Filed With SEC on March 11, 2022)
- Second Amendment to License Agreement between Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) and University of Miami dated August 11, 2009 (UMC-131, UMC-139)... (Filed With SEC on March 11, 2022)
- License Agreement by and between University of Miami and Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) dated November 19, 2013 (UMI143 and UMN 106) (Filed With SEC on March 11, 2022)
- CPRIT Grant (Filed With SEC on March 11, 2022)
- Assignment and Assumption Agreement between Heat Biologics, Inc. and Pelican Therapeutics, Inc.(f/k/a Heat Biologics II, Inc.) dated June 26, 2009 (UM131-31, UM139) (Filed With SEC on March 11, 2022)
- Amendment No. 4 to the Rights Agreement dated as of March 8, 2021 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 11, 2022)
- Form of New Incentive Option Agreement for awards subject to forfeiture (Filed With SEC on January 3, 2022)
- Form of New Non-Statutory Stock Option Agreement for awards subject to forfeiture (Filed With SEC on January 3, 2022)
- Merger Agreement, dated December 20, 2021, by and among Heat Biologics, Inc., Heat Acquisition Sub 1, Inc. and Elusys Therapeutics, Inc (Filed With SEC on December 21, 2021)
- Form of Amended and Restated Restricted Stock Agreement (Filed With SEC on December 15, 2021)
- Employment Agreement between Heat Biologics, Inc. and William Ostrander, dated as of December 13, 2021 (Filed With SEC on December 15, 2021)
- Lease between Merchants Ice II, LLC and Heat Biologics, Inc. dated October 5, 2021 (Filed With SEC on October 7, 2021)
- License Agreement (UM-97-14) between University of Miami and Heat Biologics, Inc. dated July 11, 2008 (Filed With SEC on August 11, 2021)
- License Agreement (UMD-107)between University of Miami and Heat Biologics 1, Inc. dated February 18, 2011 (Filed With SEC on August 11, 2021)
- License Agreement (UMSS114A) between University of Miami and Heat Biologics 1, Inc. dated February 18, 2011 (Filed With SEC on August 11, 2021)
- License Agreement between University of Miami and Zolovax, Inc. dated October 24, 2016 (Filed With SEC on August 11, 2021)
- Form of Stock Option Agreement for the Heat Biologics 2021 Subsidiaries Stock Incentive Plan (Filed With SEC on August 3, 2021)
- Form of Restricted Stock Purchase Agreement for the Heat Biologics 2021 Subsidiaries Stock Incentive Plan (Filed With SEC on August 3, 2021)
- Lease between Durham Keystone Tech 7, LLC and Heat Biologics, Inc. dated June 19, 2021 (Filed With SEC on June 23, 2021)
- Description of Securities of Heat Biologics, Inc (Filed With SEC on March 25, 2021)
- Amendment No. 3 to the Rights Agreement dated as of March 8, 2021 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 12, 2021)
- Exclusive License Agreement between the University of Miami and Zolovax, Inc. dated as of December 31, 2020 (Filed With SEC on January 6, 2021)
- Amendment to Offer Letter between Heat Biologics, Inc. and William Ostrander, dated as of January 4, 2021 (Filed With SEC on January 6, 2021)
- Employment Agreement between Heat Biologics, Inc. and Jeffrey Wolf, dated as of January 4, 2021 (Filed With SEC on January 6, 2021)
- Form of Restricted Stock Agreement (Filed With SEC on January 6, 2021)
- Separation Agreement dated December 31, 2020 between Heat Biologics, Inc. And Jeff Hutchins (Filed With SEC on January 6, 2021)
- Amendment to License Agreement (UMI-176) between the University of Miami and Heat Biologics, Inc. effective December 12, 2010 (Filed With SEC on December 10, 2020)
- Amendment to License Agreement (UMSS-114) between the University of Miami and Heat Biologics, Inc. effective July 11, 2008 (Filed With SEC on December 10, 2020)
- Amendment to License Agreement (D-107) between the University of Miami and Heat I, Inc. effective February 18, 2011 (Filed With SEC on December 10, 2020)
- Amendment to License Agreement (UMSS-114A) between the University of Miami and Heat I, Inc. effective February 18, 2011 (Filed With SEC on December 10, 2020)
- Amended and Restated Sales Agreement, dated August 24, 2020, among Heat Biologics, Inc., B. Riley Securities, Inc. and Cantor Fitzgerald & Co (Filed With SEC on August 24, 2020)
- Amendment No. 1, dated April 23, 2020, to the At Market Issuance Sales Agreement, by and between Heat Biologics, Inc. and B. Riley FBR, Inc. dated April 3, 2019 (Filed With SEC on April 23, 2020)
- Attachment F to CPRIT Contract (Filed With SEC on April 10, 2020)
- Description of Securities of Heat Biologics, Inc (Filed With SEC on March 30, 2020)
- Form of Exchange Agreement (Filed With SEC on March 3, 2020)
- Underwriting Agreement, dated January 16, 2020, between Heat Biologics, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on January 21, 2020)
- Form of Warrant (Filed With SEC on January 21, 2020)
- Form of Investor Agreement (Filed With SEC on January 21, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on January 13, 2020)
- Amendment to Employment Agreement between Heat Biologics, Inc. and Jeffrey Wolf, effective as of January 1, 2020 (Filed With SEC on January 3, 2020)
- Amendment to Employment Agreement between Heat Biologics, Inc. and Jeffrey T. Hutchins, effective as of January 1, 2020 (Filed With SEC on January 3, 2020)
- Amendment to Offer Letter between Heat Biologics, Inc. and William Ostrander, effective as of January 1, 2020 (Filed With SEC on January 3, 2020)
- Form of Heat Biologics, Inc. Restricted Stock Agreement (Filed With SEC on January 3, 2020)
- Attachment F to CPRIT Contract (Filed With SEC on November 22, 2019)
- Investor Agreement (Filed With SEC on November 5, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 25, 2019)
- Form of Common Stock Purchase Warrant (Filed With SEC on October 25, 2019)
- Agreement by and between Heat Biologics, Inc. and Robert J. Jakobs, dated September 20, 2019 (Filed With SEC on September 24, 2019)
- Offer Letter by and between Heat Biologics, Inc. and William L. Ostrander, dated September 23, 2019 (Filed With SEC on September 24, 2019)
- Attachment F to CPRIT Contract (Filed With SEC on April 18, 2019)
- Lease between Durham KTP Tech 7, LLC and Heat Biologics, Inc. dated April 17, 2019 (Filed With SEC on April 18, 2019)
- At Market Issuance Sales Agreement, dated April 3, 2019, by and between Heat Biologics, Inc. and B. Riley FBR, Inc (Filed With SEC on April 4, 2019)
- Amendment No. 1 to the Rights Agreement dated as of March 8, 2019 to the Rights Agreement dated March 11, 2018 by and between Heat Biologics, Inc. and Continental Stock Transfer &... (Filed With SEC on March 12, 2019)
- Agreement by and between Heat Biologics, Inc. and Ann A. Rosar, dated March 7, 2019 (Filed With SEC on March 12, 2019)
- Offer Letter by and between Heat Biologics, Inc. and Robert J. Jakobs, dated March 7, 2019 (Filed With SEC on March 12, 2019)
- Amendment to Employment Agreement between Heat Biologics, Inc. and Jeffrey T. Hutchins, effective as of January 1, 2019 (Filed With SEC on January 3, 2019)
- Heat Biologics, Inc. Form of Restricted Stock Agreement (Filed With SEC on January 3, 2019)
- Underwriting Agreement, dated November 21, 2018, between Heat Biologics, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on November 21, 2018)
- Form of Warrant (Filed With SEC on November 21, 2018)
- Underwriting Agreement by and between Heat Biologics, Inc. and A.G.P./Alliance Global Partners (A.G.P.), as representative of the underwriters, dated May 2, 2018 (Filed With SEC on May 7, 2018)
- Warrant Agency Agreement by and between Heat Biologics, Inc. and Continental Stock Transfer & Trust Company, as warrant agent, dated May 2, 2018 (Filed With SEC on May 7, 2018)
- Common Warrant (Filed With SEC on May 7, 2018)
- Form of Underwriting Agreement (Filed With SEC on May 2, 2018)
- Form of Warrant Agent Agreement between Heat Biologics, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on May 2, 2018)
- Form of Warrant Agent Agreement between Heat Biologics, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on May 2, 2018)
- Form of Warrant Agent Agreement between Heat Biologics, Inc. and Continental Stock Transfer & Trust Company (Filed With SEC on May 2, 2018)
- Form of Common Warrant (Filed With SEC on May 2, 2018)
- Form of Underwriting Agreement (Filed With SEC on April 26, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on April 19, 2018)
- Rights Agreement (Filed With SEC on March 12, 2018)
- Form of Incentive Stock Option Agreement under the 2017 Stock Incentive Plan (Filed With SEC on March 2, 2018)
- Form of Non-Statutory Stock Option Agreement under the 2017 Stock Incentive Plan (Filed With SEC on March 2, 2018)
- Form of Restricted Stock Unit Award Agreement under the 2017 Stock Incentive Plan (Filed With SEC on March 2, 2018)
- Common Stock Sales Agreement, dated January 18, 2018, by and between Heat Biologics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 19, 2018)
- Amendment to Employment Agreement between Heat Biologics, Inc. and Jeff T. Hutchins, effective as of January 1, 2018 (Filed With SEC on January 10, 2018)
- Amendment to Employment Agreement between Heat Biologics, Inc. and Ann Rosar, effective as of January 1, 2018 (Filed With SEC on January 10, 2018)
- Underwriting Agreement, dated November 17, 2017, between Heat Biologics, Inc. and Aegis Capital Corp (Filed With SEC on November 17, 2017)
- Form of Dealer-Manager Agreement by and between Heat Biologics, Inc. and Advisory Group Services, Ltd. (doing business as RHK Capital) (Filed With SEC on October 17, 2017)
- Form of Dealer-Manager Agreement by and between Heat Biologics, Inc. and RHK Capital Inc (Filed With SEC on October 10, 2017)
- Form of Subscription Rights Certificate (Filed With SEC on September 15, 2017)
- Amendment to Employment Agreement with Jeff T. Hutchins dated as of June 29, 2017 (Filed With SEC on June 30, 2017)
- Amendment to Employment Agreement with Ann Rosar dated as of June 29, 2017 (Filed With SEC on June 30, 2017)
- License Agreement by and between University of Miami and Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) dated July 11, 2008 (UM03-31, UM05-39) (Filed With SEC on May 3, 2017)
- License Agreement by and between University of Miami and Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) dated December 12, 2010 (UMI176) (Filed With SEC on May 3, 2017)
- License Agreement by and between University of Miami and Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) dated November 19, 2013 (UM-143 and UMN-106) (Filed With SEC on May 3, 2017)
- Amendment to License Agreement between Heat Biologics, Inc. and University of Miami dated April 20, 2009 (Filed With SEC on May 3, 2017)
- Assignment and Assumption Agreement between Heat Biologics, Inc. and Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) dated June 26, 2009 (UM03-31, UM05-39) (Filed With SEC on May 3, 2017)
- Second Amendment to License Agreement between Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) and University of Miami dated August 11, 2009 (UM03-31, UM05-39) (Filed With SEC on May 3, 2017)
- Payment Agreement between Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) dated December 19, 2012 (UMI176) (Filed With SEC on May 3, 2017)
- CPRIT Grant (Filed With SEC on May 3, 2017)
- Funding Commitment issued by Heat Biologics, Inc. dated April 6, 2017 (Filed With SEC on April 7, 2017)
- First Amendment to Exclusive License Agreement between The Regents of The University of Michigan and Heat Biologics, Inc. (UM File Number 3680) dated December 1, 2016 (Filed With SEC on March 31, 2017)
- First Amendment to Stock Purchase Agreement to Stock Purchase Agreement dated March 29, 2017 by and among Heat Biologics, Inc., Pelican Therapeutics, Inc. and Josiah Hornblower as... (Filed With SEC on March 31, 2017)
- Underwriting Agreement, dated March 23, 2017, between Heat Biologics, Inc. and Aegis Capital Corp (Filed With SEC on March 24, 2017)
- Stock Purchase Agreement, dated March 7, 2017, by and among Heat Biologics, Inc., Pelican Therapeutics, Inc., the stockholders of Pelican Therapeutics, Inc. party thereto (Filed With SEC on March 8, 2017)
- Amendment to Employment Agreement between Heat Biologics, Inc. and Jeffrey Wolf effective as of January 1, 2017 (Filed With SEC on January 4, 2017)
- Amendment to Employment Agreement between Heat Biologics, Inc. and Ann Rosar effective as of January 1, 2017 (Filed With SEC on January 4, 2017)
- Employment Agreement effective as of January 1, 2017 between Heat Biologics, Inc. and Jeff T. Hutchins (Filed With SEC on January 4, 2017)
- Form of Restricted Stock Unit Award Agreement (Filed With SEC on January 4, 2017)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 10, 2016)
- HEAT BIOLOGICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on August 15, 2016)
- At Market Issuance Sales Agreement, dated August 15, 2016, by and between Heat Biologics, Inc. and FBR Capital Markets & Co (Filed With SEC on August 15, 2016)
- AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on April 7, 2016)
- AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on April 7, 2016)
- AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on April 7, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on April 7, 2016)
- SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on April 7, 2016)
- SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on April 7, 2016)
- [FORM OF WARRANT] (Filed With SEC on March 18, 2016)
- HEAT BIOLOGICS, INC. [] Shares of Common Stock and Warrants to Purchase Up to [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 15, 2016)
- FORM OF WARRANT (Filed With SEC on March 15, 2016)
- HEAT BIOLOGICS, INC. [] Shares of Common Stock and Warrants to Purchase Up to [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 9, 2016)
- FORM OF WARRANT (Filed With SEC on March 9, 2016)
- Second Amendment to Loan and Security Agreement with Pacific Western Bank dated February 29, 2016 (Filed With SEC on March 3, 2016)
- Amendment to Employment Agreement between the Company and Jeffrey Wolf dated January 11, 2016 (Filed With SEC on January 15, 2016)
- Amendment to Employment Agreement between the Company and Melissa Price, Ph.D. dated January 11, 2016 (Filed With SEC on January 15, 2016)
- Amendment to Employment Agreement between the Company and Anil Goyal, Ph.D. dated January 11, 2016 (Filed With SEC on January 15, 2016)
- Amendment to Employment Agreement between the Company and Taylor Schreiber, M.D., Ph.D. dated January 11, 2016 (Filed With SEC on January 15, 2016)
- Amendment to Employment Agreement between the Company and Timothy Creech dated January 11, 2016 (Filed With SEC on January 15, 2016)
- Employment Agreement, dated as of November 30, 2015, by and between Timothy Creech and Heat Biologics, Inc (Filed With SEC on December 1, 2015)
- Amendment to Employment Agreement between the Company and Taylor Schreiber, M.D., Ph.D., dated July 23, 2015 (Filed With SEC on July 27, 2015)
- Amendment to Employment Agreement between the Company and Melissa Price, Ph.D., dated July 23, 2015 (Filed With SEC on July 27, 2015)
- Form of Incentive Stock Option Agreement under the 2014 Stock Incentive Plan, as amended (Filed With SEC on July 27, 2015)
- Form of Non-Statutory Stock Option Agreement under the 2014 Stock Incentive Plan, as amended (Filed With SEC on July 27, 2015)
- First Amendment to Loan and Security Agreement with Square 1 Bank dated June 22, 2015 (Filed With SEC on June 24, 2015)
- LEASE AGREEMENT (Filed With SEC on March 27, 2015)
- FIRST AMENDMENT TO LEASE (Filed With SEC on March 27, 2015)
- SECOND AMENDMENT TO LEASE (Filed With SEC on March 27, 2015)
- Underwriting Agreement, dated March 10, 2015, between Heat Biologics, Inc. and Aegis Capital Corp (Filed With SEC on March 12, 2015)
- Severance Agreement, dated as of March 9, 2015 with Matthew Czajkowski (Filed With SEC on March 10, 2015)
- Amendment to Employment Agreement between the Company and Anil K. Goyal, Ph.D., dated January 12, 2015 (Filed With SEC on January 16, 2015)
- Amendment to Employment Agreement between the Company and Melissa Price, Ph.D., dated January 12, 2015 (Filed With SEC on January 16, 2015)
- Amendment to Employment Agreement between the Company and Taylor Schreiber, M.D., Ph.D., dated January 12, 2015 (Filed With SEC on January 16, 2015)
- Loan Agreement with Square 1 Bank (Filed With SEC on August 25, 2014)
- Warrant issued to Square 1 Bank (Filed With SEC on August 25, 2014)
- Amendment to Employment Agreement between the Company and Matthew Czajkowski dated May 1, 2014 (Filed With SEC on May 7, 2014)
- Lease Agreement dated January 24, 2014 (Filed With SEC on March 31, 2014)
- License Agreement (UMK-161) between the University of Miami and its School of Medicine and Heat Biologics I, Inc. effective March 4, 2014 (Filed With SEC on March 31, 2014)
- Employment Agreement, dated as of March 3, 2014, by and between Dr. Schreiber and the Company (Filed With SEC on March 5, 2014)
- Amendment to Employment Agreement between the Company and Matthew Czajkowski dated January 20, 2014 (Filed With SEC on January 21, 2014)
- Amendment to Employment Agreement between the Company and Melissa Price dated January 20, 2014 (Filed With SEC on January 21, 2014)
- Amendment to Employment Agreement between the Company and Jeffrey Wolf dated January 20, 2014 (Filed With SEC on January 21, 2014)
- Employment Agreement, dated as of December 16, 2013, by and between Anil K. Goyal and the Company (Filed With SEC on December 19, 2013)
- Employment Agreement, dated as of October 1, 2013, by and between Melissa Price and the Company (Filed With SEC on October 1, 2013)
- Form of Underwriting Agreement between Heat Biologics, Inc. and Aegis Capital Corp., as representative of the several underwriters (Filed With SEC on May 30, 2013)
- Warrant issued to North Carolina Biotechnology Center (Filed With SEC on May 30, 2013)
- Form of Representatives Warrant (Filed With SEC on May 30, 2013)
- AMENDMENT TO STOCK WARRANT (Filed With SEC on May 30, 2013)
- AMENDMENT TO WARRANT TO PURCHASE STOCK (Filed With SEC on May 30, 2013)
- Employment Agreement with Jennifer Harris dated November 3, 2011 and amendment thereto dated May 1, 2013 (Filed With SEC on May 30, 2013)
- Employment Agreement with Matthew Czajkowski dated May 15, 2013 (Filed With SEC on May 30, 2013)
- Form of Lock-up Agreement (Filed With SEC on May 30, 2013)
- Form of Agreement with Series B Preferred Stockholders to amend Stock Purchase Agreement (Filed With SEC on May 30, 2013)
- HEAT BIOLOGICS, INC. 2009 STOCK INCENTIVE PLAN (Filed With SEC on May 6, 2013)
- FIRST AMENDMENT OF THE HEAT BIOLOGICS, INC. 2009 STOCK INCENTIVE PLAN (Filed With SEC on May 6, 2013)
- SECOND AMENDMENT OF THE HEAT BIOLOGICS, INC. 2009 STOCK INCENTIVE PLAN (Filed With SEC on May 6, 2013)
- THIRD AMENDMENT OF THE HEAT BIOLOGICS, INC. 2009 STOCK INCENTIVE PLAN (Filed With SEC on May 6, 2013)
- FOURTH AMENDMENT OF THE HEAT BIOLOGICS, INC. 2009 STOCK INCENTIVE PLAN (Filed With SEC on May 6, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on May 6, 2013)
- ________________________ STOCK WARRANT (Filed With SEC on May 6, 2013)
- Number (Filed With SEC on May 6, 2013)
- SERIES B PREFERRED STOCK PURCHASE AGREEMENT AMONG HEAT BIOLOGICS, INC. AND THE UNDERSIGNED PURCHASERS DATED AS OF MARCH 25, 2013 TABLE OF CONTENTS (Filed With SEC on May 6, 2013)
- LICENSE AGREEMENT (Filed With SEC on May 6, 2013)
- LICENSE AGREEMENT (Filed With SEC on May 6, 2013)
- LICENSE AGREEMENT (Filed With SEC on May 6, 2013)
- LICENSE AGREEMENT (Filed With SEC on May 6, 2013)
- LICENSE AGREEMENT (Filed With SEC on May 6, 2013)
- PROMISSORY NOTE (Filed With SEC on May 6, 2013)
- LOAN AGREEMENT (Filed With SEC on May 6, 2013)
- COMMON STOCK SUBSCRIPTION AGREEMENT (Filed With SEC on May 6, 2013)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 6, 2013)
- FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on May 6, 2013)
- RENT SUMMARY Heat Biologics (Tenant) 2,111 (Sq Ft) (Filed With SEC on May 6, 2013)
- Non-Exclusive Evaluation and Biological Material License Agreement By And Between American Type Culture Collection (ATCC) And Heat Biologics, Inc. TABLE OF CONTENTS (Filed With SEC on May 6, 2013)
- MANUFACTURING SERVICES AGREEMENT (Filed With SEC on May 6, 2013)
- ASSIGNMENT AND ASSUMPTION AGREEMENT (UMSS-114) (Filed With SEC on May 6, 2013)
- TERMINATION AGREEMENT (UMSS97-14) (Filed With SEC on May 6, 2013)
- HEAT BIOLOGICS, INC. HEAT BIOLOGICS I, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on May 6, 2013)
- APPENDIX A CONFIDENTIAL INFORMATION AND ASSIGNMENT OF INVENTIONS (Filed With SEC on May 6, 2013)
- AMENDMENT TO LICENSE AGREEMENT (UM97-14) (Filed With SEC on May 6, 2013)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 6, 2013)
- SECOND AMENDMENT TO LICENSE AGREEMENT (UMSS-114) (Filed With SEC on May 6, 2013)
- EXCLUSIVE LICENSE AGREEMENT University of Michigan File 3680 (Filed With SEC on May 6, 2013)
- 1st LEASE MODIFICATION AGREEMENT (Filed With SEC on May 6, 2013)
- CO-SALE AND FIRST REFUSAL AGREEMENT (Filed With SEC on May 6, 2013)
- VOTING AGREEMENT (Filed With SEC on May 6, 2013)
- INVESTORS RIGHTS AGREEMENT (Filed With SEC on May 6, 2013)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 6, 2013)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 6, 2013)
- FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 6, 2013)
- OPTION CONTRACT FOR EXCLUSIVE LICENSE (Filed With SEC on May 6, 2013)
- FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 6, 2013)